Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

NCT06140407 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low accrual and Merck discontinuing funding and drug supply

Conditions

Limited Stage Lung Small Cell Carcinoma
Stage I Lung Cancer
Stage II Lung Cancer
Stage III Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Etoposide
BIOLOGICAL: Pembrolizumab
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Biospecimen Collection
RADIATION: Radiation Therapy

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]